Skip to main content
53°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Xencor Inc
(NQ:
XNCR
)
21.62
+0.36 (+1.72%)
Streaming Delayed Price
Updated: 3:16 PM EST, Nov 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Xencor Inc
< Previous
1
2
3
4
5
6
Next >
Xencor to Host First Quarter 2023 Financial Results Webcast and Conference Call on May 8, 2023
May 01, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Appoints Nancy Valente, M.D., as Chief Development Officer
April 26, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Highlights CD28 Bispecific Antibody Platform at AACR Annual Meeting 2023
April 17, 2023
From
Xencor, Inc.
Via
Business Wire
Why Shares of Zencor Rose This Week
January 26, 2023
The clinical-stage biotech has seen its shares rise since a company presentation a few weeks ago.
Via
The Motley Fool
Xencor's Return On Capital Employed Overview
December 01, 2022
Via
Benzinga
7 Biotech Stocks to Buy for 100% Returns
April 09, 2023
If you can handle the risks associated with high volatility, these biotech stocks to buy might double the returns in your portfolio.
Via
InvestorPlace
Xencor to Present Preclinical Data from Novel XmAb® CD28 Bispecific Antibody Programs at the American Association for Cancer Research Annual Meeting 2023
March 14, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Reports Fourth Quarter and Full Year 2022 Financial Results
February 23, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on February 23, 2023
February 16, 2023
From
Xencor, Inc.
Via
Business Wire
Earnings Scheduled For February 23, 2023
February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
Via
Benzinga
Top 5 Health Care Stocks That May Collapse In February
February 13, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Xencor to Present at the SVB Securities Global Biopharma Conference
February 07, 2023
From
Xencor, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2023
January 31, 2023
Via
Benzinga
3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023
January 13, 2023
Health care stocks are trying to make a comeback and these three small-cap biopharma companies are leading the charge in some ways.
Via
MarketBeat
Benzinga's Top Ratings Upgrades, Downgrades For January 30, 2023
January 30, 2023
Via
Benzinga
Xencor Highlights 2023 Corporate Priorities and Provides Portfolio Updates
January 09, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Presents Data from Phase 1 Study of Plamotamab in Relapsed or Refractory Non-Hodgkin Lymphoma at the American Society of Hematology Annual Meeting
December 12, 2022
From
Xencor, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022
December 06, 2022
Via
Benzinga
Xencor to Present at Upcoming Investor Conferences
November 10, 2022
From
Xencor, Inc.
Via
Business Wire
Xencor Presents Early Clinical Data from Combination Study of Vudalimab and New Data from Multiple Preclinical-stage XmAb® Programs at the SITC Annual Meeting
November 10, 2022
From
Xencor, Inc.
Via
Business Wire
Xencor Reports Third Quarter 2022 Financial Results
November 07, 2022
From
Xencor, Inc.
Via
Business Wire
Xencor’s IL2-Fc Cytokine, XmAb®564, is Well-tolerated and Selectively Expands Regulatory T Cells in Phase 1a Clinical Study
November 07, 2022
From
Xencor, Inc.
Via
Business Wire
Earnings Scheduled For November 7, 2022
November 07, 2022
Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million.
Via
Benzinga
Xencor Earnings Preview
November 04, 2022
Xencor (NASDAQ:XNCR) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Xencor will report an...
Via
Benzinga
Xencor to Present New Clinical Data from the Phase 1 Study of Plamotamab in Relapsed or Refractory Non-Hodgkin’s Lymphoma at the American Society of Hematology Annual Meeting
November 03, 2022
From
Xencor, Inc.
Via
Business Wire
Xencor to Host Third Quarter 2022 Financial Results Webcast and Conference Call on November 7, 2022
October 31, 2022
From
Xencor, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
October 13, 2022
Upgrades
Via
Benzinga
Xencor to Present Seven Posters on Multiple Clinical Trials and Research-stage Programs at the SITC Annual Meeting
October 05, 2022
From
Xencor, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022
September 21, 2022
Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the year-ago...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.